IBCI enters second round of testing for microbial agents
into the second round of testing in a cooperative effort with a
global food and beverage company after initial testing for its
antimicrobial agents proved effective.
International BioChemical Industries has said that it has moved into the second round of testing in a cooperative effort with a global food and beverage company after initial testing for its antimicrobial agents proved effective.
Deirdre Baker, IBCI's General Manager stated, "We have now entered into a new phase of expanding the use of our technology in the food and beverage industry, in which the company has spent five years in development and multiple years in patent protection as announced on November 19, 2002. As a result of this continuing effort, new technologies and new applications for IBCI's antimicrobial agents may be developed in the marketplace. We are confident from the initial test results that this second phase should prove our technology successful."
As the agreement has still not reached the final stage, the company with whom IBCI is currently working together with cannot be named.
In September of this year the company changed its name from BioShield Technologies to International BioChemical Industries, in what the company termed a re-branding initiative.
International BioChemical Industries is a Georgia, US-based emerging growth company focused in biotechnology and antimicrobial products. Its core business is committed to the discovery, development, marketing and sale of surface-modifying antimicrobial and biostatic products.
The company's antimicrobial technology is a new alternative to conventional sanitisers, disinfectants, bleaches, biocides or preservatives primarily because it kills bacteria on contact and can remain active for extended time periods. To date BioShield has received three US patents and six EPA registrations, including the first US germ killer and disinfectant against Salmonella cholerasuis, Staphylococcus aureus and other microorganisms.
